Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (611-620 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|April 18, 2024
Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post-essential thrombocythemia myelofibrosis: A case reportMahija Cheekati, KarLeung Siu, Rachel Ochs
Ejhaem|April 18, 2024
A decade of chronic lymphocytic leukaemia therapy in Germany: Real-world treatment patterns and outcomes (2010-2022)Hannes Wartmann, Anna Kabilka, Barthold Deiters, et al.
Ejhaem|January 26, 2026
Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome PatientLiya Ma, Yaojia Shen, Jie Chang, et al.
Ejhaem|February 2, 2026
Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive CohortA Coste, S Godet, S Manier, et al.
Ejhaem|February 2, 2026
Venous Thromboembolism in Aggressive B-Cell Lymphoma Patients Treated with CD19 CAR-T Therapy: Single-Institution StudyNeha Venkatesh, Kevin Milligan, Julia Parrish, et al.
Ejhaem|December 12, 2025
Efficacy and Safety of Pegfilgrastim in Patients With Severe Congenital NeutropeniaMahdiyeh Movahedi, Leila Moradi, Zahra Alizadeh, et al.
Ejhaem|December 12, 2025
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in IndiaGeorge John, Sumeet Mirgh, Sachin Punatar, et al.
Ejhaem|November 28, 2025
Anaphylaxis During CAR T-Cell Infusion in an HIV-Positive Patient With High-Grade B-Cell Lymphoma: A Case Report and Literature ReviewMostafa F Mohammed Saleh, Abdulrahman Nasiri, Ahmed Alahmadi, et al.
Ejhaem|November 27, 2025
Donor-Derived T-Cell Redirection With Epcoritamab Achieving Complete Response After Early Post-Allo-HSCT Relapse of DLBCLYoshikazu Ikoma, Yuto Kaneda, Ryoma Shimazu, et al.
Ejhaem|December 1, 2025
Baseline Cytomegalovirus Immunoglobulin G Levels Predict Reactivation in Patients With Multiple Myeloma Receiving ElranatamabUkyo Kondo, Taku Kikuchi, Shotaro Sugita, et al.
Pageof 93

Showing results (611-620 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|April 18, 2024
Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post-essential thrombocythemia myelofibrosis: A case reportMahija Cheekati, KarLeung Siu, Rachel Ochs
Ejhaem|April 18, 2024
A decade of chronic lymphocytic leukaemia therapy in Germany: Real-world treatment patterns and outcomes (2010-2022)Hannes Wartmann, Anna Kabilka, Barthold Deiters, et al.
Ejhaem|January 26, 2026
Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome PatientLiya Ma, Yaojia Shen, Jie Chang, et al.
Ejhaem|February 2, 2026
Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive CohortA Coste, S Godet, S Manier, et al.
Ejhaem|February 2, 2026
Venous Thromboembolism in Aggressive B-Cell Lymphoma Patients Treated with CD19 CAR-T Therapy: Single-Institution StudyNeha Venkatesh, Kevin Milligan, Julia Parrish, et al.
Ejhaem|December 12, 2025
Efficacy and Safety of Pegfilgrastim in Patients With Severe Congenital NeutropeniaMahdiyeh Movahedi, Leila Moradi, Zahra Alizadeh, et al.
Ejhaem|December 12, 2025
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in IndiaGeorge John, Sumeet Mirgh, Sachin Punatar, et al.
Ejhaem|November 28, 2025
Anaphylaxis During CAR T-Cell Infusion in an HIV-Positive Patient With High-Grade B-Cell Lymphoma: A Case Report and Literature ReviewMostafa F Mohammed Saleh, Abdulrahman Nasiri, Ahmed Alahmadi, et al.
Ejhaem|November 27, 2025
Donor-Derived T-Cell Redirection With Epcoritamab Achieving Complete Response After Early Post-Allo-HSCT Relapse of DLBCLYoshikazu Ikoma, Yuto Kaneda, Ryoma Shimazu, et al.
Ejhaem|December 1, 2025
Baseline Cytomegalovirus Immunoglobulin G Levels Predict Reactivation in Patients With Multiple Myeloma Receiving ElranatamabUkyo Kondo, Taku Kikuchi, Shotaro Sugita, et al.
Pageof 93